Guideline for Postmarketing Chinese Medicine Pharmacoeconomic Evaluation  

作　　者：王昕 王志飞 谢雁鸣 张雯 廖星 常艳鹏 

机构地区：[1]Institute of Basic Research in Clinical Medicine,China Academy of Chinese Medical Sciences [2]Beijing Bionovo Medicine Development Co.,Ltd.

出　　处：《Chinese Journal of Integrative Medicine》2015年第6期473-480,共8页中国结合医学杂志（英文版）

基　　金：Supported by Research on Key Techniques of Reevaluation of Postmarketing Chinese Medicines,the Ministry of Science and Technology(No.2009ZX09502-030);the Seventh-Science Foundation of China Academy of Chinese Medical Sciences(No.ZZ070817);National Natural Science Foundation of China(General program,No.81202776)

摘　　要：Pharmacoeconomics is an important part of the postmarketing Chinese medicine （CM） evaluation, and postmarketing pharmacoeconomic evaluation can reveal the clinical and market value of CM. The purpose of establishing the guideline for pharmacoeconomic evaluation is to make the evaluation process and results regarding Chinese patent medicines both scientific and fair. Every country＇s guidelines for pharmacoeconomic evaluation act as reference guidelines, we have already drawn up the guideline that takes into account the special characteristics of CM; and these are in preparation for the postmarketing CM pharmacoeconomic evaluation.Pharmacoeconomics is an important part of the postmarketing Chinese medicine （CM） evaluation, and postmarketing pharmacoeconomic evaluation can reveal the clinical and market value of CM. The purpose of establishing the guideline for pharmacoeconomic evaluation is to make the evaluation process and results regarding Chinese patent medicines both scientific and fair. Every country＇s guidelines for pharmacoeconomic evaluation act as reference guidelines, we have already drawn up the guideline that takes into account the special characteristics of CM; and these are in preparation for the postmarketing CM pharmacoeconomic evaluation.

关 键 词：postmarketing evaluation Chinese medicine PHARMACOECONOMICS GUIDELINE 

分 类 号：F426.72[经济管理—产业经济] R28[医药卫生—中药学]